| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ayala Pharmaceuticals, Inc. (ADXS) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 9 sells. ADXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2016 | Petit Robert | Chief Scientific Officer | Sell | 3,099 | $6.88 | $21,321.12 | -2.3% | |
| Jan 29, 2016 | O'Connor Daniel | Chief Executive Officer | Sell | 8,818 | $6.88 | $60,667.84 | -2.7% | |
| Dec 17, 2015 | Berman Richard J87 | Director | Sell | 14,332 | $12.39 | $177,573.48 | -14.5% | |
| Oct 30, 2015 | Petit Robert | Chief Scientific Officer | Sell | 2,867 | $12.26 | $35,149.42 | -2.1% | |
| Oct 30, 2015 | O'Connor Daniel | Chief Executive Officer | Sell | 8,350 | $12.26 | $102,371.00 | -2.5% | |
| Oct 26, 2015 | Mayes, Gregory T. | Chief Operating Officer | Sell | 19,231 | $11.63 | $223,656.53 | -13.8% | |
| Oct 20, 2015 | Mauro David J90 | Chief Medical Officer | Sell | 24,586 | $10.08 | $247,826.88 | -12.9% | |
| Aug 24, 2015 | Adage Capital Partners GP LLC64 | 10% Owner | Buy | 300,000 | $14.15 | $4,246,337.28 | +0.5% | |
| Jul 31, 2015 | Petit Robert | Chief Scientific Officer | Sell | 2,943 | $15.44 | $45,439.92 | -2.1% | |
| Jul 31, 2015 | O'Connor Daniel | Chief Executive Officer | Sell | 8,449 | $15.44 | $130,452.56 | -2.4% |